Oncoinfo
@oncoinfo_it
Latest research in oncology | Breaking news, insights, interviews, live tweeting and updates from major conferences | Published by @ilpensiero | @think2it
ID: 1565672671
http://oncoinfo.it/ 03-07-2013 12:26:05
5,5K Tweet
5,5K Followers
4,4K Following
#ESMO24 | #Melanoma: why we choose #neoadjuvant immunotherapy? Here are Sapna’s reasons 👇🏼 ESMO - Eur. Oncology Sapna Patel Christian Blank Paolo A. Ascierto
